Vaccinia virus complement control protein inhibits hyperacute xenorejection.
Anderson
J B
JB
Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
Smith
S A
SA
Kotwal
G J
GJ
D000818:Animals; D006084:Graft Rejection / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D010843:Pichia; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000494:pharmacology; D015996:Survival Rate; D014183:Transplantation, Heterologous / Q000276:immunology*; D014616:Vaccinia virus / Q000276:immunology; D014764:Viral Proteins / Q000494:pharmacology*
D011994:Recombinant Proteins; D014764:Viral Proteins; C066459:complement-control protein, Vaccinia virus